Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5336-5342

  González, Frank ^a,b   Minium, Judi ^a   Rote, Neal S ^a   Kirwan, John P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENITAL SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH CENTER; HUMAN; HYPERGLYCEMIA; INGESTION; INSULIN SENSITIVITY; MONONUCLEAR CELL; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MONOCYTES; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24344501691     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0694     Document Type: Article

References (56)

1. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
2. Knochenhauer ES, Key TJ, Kahser-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern Unites States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS Conference Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
4. The Rotterdam ESHRE/ASRM-Sponsored PCOS Conference Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19:41-47
5. Goodarzi MO, Korenman SG 2002 The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 77:255-258
6. Burghen GA, Givens JR, Kitabachi AE 1980 Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116
7. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositoglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
8. Kolterman OG, Insel J, Saekow M, Olefsky JM 1980 Mechanisms of insulin resistance in human obesity. Evidence for receptor and post receptor defects. J Clin Invest 65:1272-1284
9. Ciaraldi TP, Kolterman OG, Olefsky JM 1981 Mechanism for the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest 68:875-878
10. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N 2001 Low grade chronic inflammation in women in women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:2453-2455
11. Boulman N, Leiba LR, Shachar S, Linn R, Zinder O, Blumenfeld Z 2004 Increased c-reactive protean levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89:2160-2165
12. Morin-Papunen L, Bautio K, Ruokonen A, Hedberg P 2003 Metformin reduces serum c-reactive protein levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:4649-4654
13. Laing I, Yates AP, Mather E, Pickersgill M 2003 Serum C-reactive protein is related to age and body mass index in patients with polycystic ovary syndrome but not to insulin sensitivity. Endocr Abstr 6:OC12 (Abstr)
14. González F, Thusu K, Rahman EH, Tomani M, Dandona P 1999 Elevated serum levels of tumor necrosis factor in normal-weight women with polycystic ovary syndrome. Metabolism 48:437-441
15. Sayin N, Gücer F, Balkanli-Kaplan P, Yüce M, Ciftci S, Kucuk M, Yardim T 2003 Elevated serum TNF-levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 48:165-170
16. Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker A, Bellastella A, Carella C, Izzo A 2003 Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101:1177-1182
17. Hotamisligal GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor α: direct role in obesity linked insulin resistance. Science 259:87-91
18. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Speigelman BM 1995 Increased adipose tissue expression of tumor necrosis factor α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
19. Hotamisligil GS, Murray DL, Choy LN, SpiegelmanBM1994 Tumor necrosis factor inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858
20. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A 1993 Tumor necrosis factor suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
21. 12 muscle cells. Am J Physiol Endocrinol Metab 276:E849-E855
22. Stephens JM, Pekala PH 1991 Transcriptional repression of the GLUT 4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor α. J Biol Chem 266:21839-21845
23. Rosenbaum D, Haber RS, DunaifA1993 Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT 4 glucose transporters in adipocytes. Am J Physiol 264:E197-E202
24. Dunaif A 1993 Insulin resistance in polycystic ovary syndrome. Ann NY Acad Sci 687:60-64
25. Kirchengast S, Huber J 2001 Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255-1260
26. Ibanez L, de Zegher F 2004 Ethinylestradiol-drospirenone, Flutamide-Metformon, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 89:1592-1597
27. Ibanez L, de Zegher F 2004 Flutamide-Metformon plus an oral contraceptive (OC) for women with polycystic ovary syndrome: switch from third- to fourthgeneration OC reduces body adiposity. Hum Reprod 19:1725-1727
28. Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS 1999 Bone mineral density and body composition in lean women with polycystic ovary syndrome. Fertil Steril 72:21-25
29. Yildirim B, Sabir N, Kaleli B 2003 Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 79:1358-1364
30. Wellen KE, Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788
31. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante JrAW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
32. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830
33. Fain JN, Bahouth SW, Madan AK 2004 TNFα release by nonfat cells of adipose tissue. Int J Obes 28:616-622
34. Fain JN, Madan AK, Hyler ML, Cheema P, Bahouth SM 2004 Comparison of the release of adiponectin by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
35. Evans JL, Goldfine ID, Maddux BA, Grodsky GM 2002 Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
36. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P 2000 Glucose challenge stimulates reactive oxygen species generation by leucocytes. J Clin Endocrinol Metab 85:2970-2973
37. Barnes PJ, Karin M 1997 Nuclear factor-κB: a pivitol transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
38. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ 2001 Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab 281:E1137-E1143
39. González F, Rote NS, Kirwan JP 2004 Obesity in reproductive age women is associated with altered TNFα release from mononuclear cells during glucose challenge. Diabetes Suppl 53:A567 (Abstr)
40. Modan M, Harris MI, Halkin H 1989 Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes 38:1630-1635
41. Matsuda M, DeFronzo R 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462-1470
42. Kohrt WM, Kirwan JP, King DS, Staten MA, Holloszy JO 1993 Insulin resistance of aging is related to abdominal obesity. Diabetes 42:273-281
43. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A 1998 Body mass index, waist girth, and waist to hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 67:44-49
44. Boyam A 1968 Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(Suppl 97):77-89
45. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
46. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F 1999 Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99:2221-2222
47. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T 1998 Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
48. West MA, Heagy W 2002 Endotoxin tolerance: a review. Critical Care Med Suppl 30:S64-S73
49. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Shildberg FW 1995 Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347
50. Lemaire LC, van der Poll T, van Lanschot JJB, Endert E, Buurman WA, van Deventer SJ 1998 Minimal invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia. J Clin Immunol 18:414-420
51. van Nieuwenhoven ALV, Bouman A, Moes H, Heineman MJ, de Leij LFMH, Santema J, Faas MM 2003 Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle. Obstet Gynecol 188:1073-1077
52. Ziegler-Heitbrock L 2001 The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res 7:219-222
53. Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN 2002 Dysregulation of LPS-induced tool-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 169:5209-5216
54. Kriktetos AD, Greenfiels JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV 2004 Inflammation, insulin resistance, and adiposity. Diabetes Care 27:2033-2040
55. Linne Y 2004 Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 5:137-143
56. BodenG2001 Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 7:44-51